179 related articles for article (PubMed ID: 31602725)
1. Atrial fibrillation is frequent but does not affect risk stratification in pulmonary embolism.
Ebner M; Rogge NIJ; Parwani AS; Sentler C; Lerchbaumer MH; Pieske B; Konstantinides SV; Hasenfuß G; Wachter R; Lankeit M
J Intern Med; 2020 Jan; 287(1):100-113. PubMed ID: 31602725
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
3. Syncope in the German Nationwide inpatient sample - Syncope in atrial fibrillation/flutter is related to pulmonary embolism and is accompanied by higher in-hospital mortality.
Keller K; Hobohm L; Münzel T; Ostad MA
Eur J Intern Med; 2019 Apr; 62():29-36. PubMed ID: 30770163
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
5. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism.
Binder L; Pieske B; Olschewski M; Geibel A; Klostermann B; Reiner C; Konstantinides S
Circulation; 2005 Sep; 112(11):1573-9. PubMed ID: 16144990
[TBL] [Abstract][Full Text] [Related]
8. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
[TBL] [Abstract][Full Text] [Related]
9. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
[TBL] [Abstract][Full Text] [Related]
10. [NT-proBNP for risk stratification of pulmonary embolism].
Dores H; Fonseca C; Leal S; Rosário I; Abecasis J; Monge J; Correia MJ; Bronze L; Leitão A; Arroja I; Aleixo A; Silva A
Rev Port Cardiol; 2011 Dec; 30(12):881-6. PubMed ID: 22100750
[TBL] [Abstract][Full Text] [Related]
11. Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.
Ma XX; Zhang YL; Hu B; Jiang WJ; Wang M; Zheng DY; Zhu MR; Xue XP
J Interv Card Electrophysiol; 2017 Apr; 48(3):343-350. PubMed ID: 27943042
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
[TBL] [Abstract][Full Text] [Related]
13. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
[TBL] [Abstract][Full Text] [Related]
14. Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.
Hald EM; Rinde LB; Løchen ML; Mathiesen EB; Wilsgaard T; Njølstad I; Brækkan SK; Hansen JB
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29378729
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation in acute pulmonary embolism: prognostic considerations.
Barra SN; Paiva LV; Providência R; Fernandes A; Leitão Marques A
Emerg Med J; 2014 Apr; 31(4):308-12. PubMed ID: 23349355
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation.
Fu S; Jiao J; Guo Y; Zhu B; Luo L
BMC Geriatr; 2019 Feb; 19(1):56. PubMed ID: 30819103
[TBL] [Abstract][Full Text] [Related]
17. Retrospective cohort study of new-onset atrial fibrillation in acute pulmonary embolism on prognosis.
Liu D; Shi S; Liu X; Ye T; Wang L; Qu C; Yang B; Zhao Q
BMJ Open; 2021 Sep; 11(9):e047658. PubMed ID: 34551942
[TBL] [Abstract][Full Text] [Related]
18. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
[TBL] [Abstract][Full Text] [Related]
19. The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism.
Ng AC; Adikari D; Yuan D; Lau JK; Yong AS; Chow V; Kritharides L
PLoS One; 2016; 11(3):e0150448. PubMed ID: 26930405
[TBL] [Abstract][Full Text] [Related]
20. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
